Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-28, Stock:JNJ, The news for the past five days is as follows:
2020-09-21: NEWS1: Illumina Announces $8 Billion Acquisition Of Former Cancer-Testing Spinoff Grail.NEWS2: Johnson & Johnson stock falls Monday, underperforms market.NEWS3: Instead of Going Public, Cancer-Testing Spinoff Grail Is Returning to Illumina.NEWS4: Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain..NEWS5: Trump suggests Pfizer could win U.S. COVID-19 vaccine approval, JNJ to come later.NEWS6: Why Legend Biotech Stock Is Sinking Today.
2020-09-22: NEWS1: Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know.NEWS2: Johnson & Johnson stock underperforms Tuesday when compared to competitors.
2020-09-23: NEWS1: The Covid-19 Vaccine Candidates That Are Now in Phase 3 Trials.NEWS2: Johnson & Johnson Starts Late-Stage Coronavirus Vaccine Clinical Trial.NEWS3: Johnson & Johnson stock outperforms competitors on strong trading day.NEWS4: Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 Vaccine.NEWS5: California Will Ban Sales of Gas-Powered Vehicles Starting in 2035.NEWS6: Dow Drops 400 Points as Fed Warns More Stimulus Is Needed, Tech Tumbles.NEWS7: Cramer Reacts To Johnson & Johnson's Coronavirus Vaccine Update: 'Not A Hype Company'.NEWS8: Coronavirus update: U.S. death toll tops 201,000, as daily tally more than doubles.NEWS9: Dow Jones Red Despite Big Nike Rally; Nasdaq Drops As Tech Stocks Sell Off.NEWS10: Stocks Tumble as Recovery Worries Add to Volatility, Tesla Slides.NEWS11: EU close to concluding preliminary talks with Novavax on COVID vaccine supply - source.NEWS12: US STOCKS-Wall Street retreats as business activity slows.NEWS13: Why Vaxart Stock Is Retreating Today.NEWS14: The Dow Is Struggling, and Tesla Stock Slumps.NEWS15: Justice Department Seeks to Limit Protections for Internet Companies.NEWS16: FDA commissioner: It's up to drug makers developing vaccines to seek approval or EUA.NEWS17: Fauci predicts U.S. will know if COVID-19 vaccines are effective by &quot;November or December&quot;.NEWS18: Stocks Waver as Recovery Worries Add to Volatility.NEWS19: J&J Launches Trial of Single-Dose Covid Vaccine. Results Could Come Quicker Than You Think..NEWS20: Nike, Johnson & Johnson share gains lead the way, but Dow flat.NEWS21: House Passes Spending Bill to Keep Government Funded Through Dec. 11.NEWS22: US STOCKS-S&P 500, Nasdaq retreat as business activity dips.NEWS23: Tesla's Battery Day Fizzles, J&J's Phase 3 Sizzles.NEWS24: Dow Jones Today Jumps, Nasdaq Dips As Nike Rallies; J&J Vaccine Enters Phase 3.NEWS25: P/E Ratio Overview: Johnson & Johnson.NEWS26: Johnson & Johnson Launches Phase 3 Coronavirus Vaccine Trial, Shares Jump.NEWS27: Nike, Boeing share gains contribute to Dow's 135-point climb.NEWS28: Economic Data Deluge.NEWS29: Return On Capital Employed Overview: Johnson & Johnson.NEWS30: Dow Trades Higher as Nike Surges on Big Earnings Beat.NEWS31: Dow rises over 100 points as stocks continue rebound from selloff.NEWS32: Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021.NEWS33: Dow Jones Today Jumps, Futures Mixed As Nike Rallies; J&J Vaccine Enters Phase 3.NEWS34: Johnson & Johnson Stock Is Jumping, General Mills Is Gaining, and the Dow Is Joining the Party.NEWS35: Johnson & Johnson's stock rallies after Phase 3 trial launched for COVID-19 vaccine candidate.NEWS36: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate.NEWS37: J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers.NEWS38: Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate.
2020-09-24: NEWS1: All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS2: Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine.NEWS3: Johnson & Johnson stock rises Thursday, still underperforms market.NEWS4: Moderna Stock Can’t Go Much Higher—Even If It Makes a Covid-19 Vaccine.NEWS5: FDA flags health risks from 'Benadryl Challenge'.NEWS6: Coronavirus update: Trump suggests he may overrule FDA vaccine approval; airlines ramp up testing.NEWS7: Morning Bell With Jim Cramer: Is Johnson & Johnson a Buy?.NEWS8: Current Updates On COVID-19 Vaccine.NEWS9: U.S. appeals court rejects novel opioid settlement framework.NEWS10: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS11: Moderna May Be Too Lofty, Even If It Makes a Covid-19 Vaccine, Analyst Says.NEWS12: With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?.NEWS13: Dow Jones Today, Stocks Rebound Off Opening Lows; Tesla Drags On Nasdaq; Jefferies Financial, Owens & Minor Spike.NEWS14: Dow Jones Today, Futures Turn Lower As Tesla Drags On Nasdaq; Jefferies Financial, Owens & Minor Spike.NEWS15: The Stock Market Is Having a September to Forget.NEWS16: 3 Stocks to Buy Ahead of the Next Market Crash.NEWS17: A List of All the Covid-19 Vaccine Candidates That Are Now in Final Trials.NEWS18: Top 3 Dividend Stocks You'll Want to Own Forever.NEWS19: For Investors, Is Owning Johnson & Johnson Stock a Vice or a Virtue?.NEWS20: Johnson & Johnson Begins Final Stage Trial of COVID-19 Vaccine; Target Price $170.NEWS21: PRESS DIGEST- New York Times business news - Sept 24.NEWS22: Trump Says Kentucky Attorney General Is Handling Breonna Taylor Situation ‘Very Well’.NEWS23: Trump says Kentucky attorney general is ‘handling’ Breonna Taylor situation ‘very well’ and refuses to commit to peaceful transition of power.
2020-09-25: NEWS1: Chesapeake Utilities to Join S&P SmallCap 600.NEWS2: Dow Jones Finishes Week With Strong Gains; This Leaderboard Stock Is In Buy Range.NEWS3: Johnson & Johnson stock rises Friday, still underperforms market.NEWS4: Analyst Report: Johnson & Johnson.NEWS5: Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial.NEWS6: There are four coronavirus vaccines in late-stage studies — here’s how they differ.NEWS7: Why Covid-19 Vaccine Prices May Be Unexpectedly Low.NEWS8: Dow Jones Up 100 Points After Early Dive; Apple, Microsoft Lead Tech Stock Rally.NEWS9: J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodies.NEWS10: Dow Jones Comes Back From Early Dive; Apple, Microsoft Lead Tech Stock Rally.NEWS11: U.S. nears 7M coronavirus cases, big pharmaceutical companies race for a vaccine.NEWS12: J&J signs manufacturing deal with GRAM for potential COVID-19 vaccine.NEWS13: Is JNJ Stock A Buy As Pharma Giant Starts Final-Phase Coronavirus Vaccine Trials?.NEWS14: Another Covid-19 Vaccine Candidate Is in the Final Stage of Testing.NEWS15: Novavax Is Starting a Phase 3 Trial of Its Covid-19 Vaccine. The Stock Is Jumping..NEWS16: 3 Dividend Aristocrats to Buy and Hold Forever.NEWS17: Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock.

Answer: Rise